Navigation Links
BD Announces Results For 2011 First Fiscal Quarter
Date:2/7/2011

guidance, resulted from certain first quarter events, including the retroactive extension of the U.S. research tax credit.

Segment ResultsIn the BD Medical segment, worldwide revenues for the quarter were $927 million, representing a decrease of 4.5 percent compared with the prior-year period, or a decrease of 4.3 percent on a foreign currency-neutral basis. The segment's revenue decline reflects an unfavorable comparison to the prior year of about 6 percentage points due to strong sales related to the H1N1 flu pandemic in fiscal year 2010, partially offset by solid growth in the Diabetes Care unit with particularly strong growth in pen needles.

In the BD Diagnostics segment, worldwide revenues for the quarter were $602 million, representing an increase of 1.0 percent compared with the prior-year period, or 0.6 percent on a foreign currency-neutral basis.  Segment revenue growth was negatively impacted by about 2 percentage points due to strong sales related to the flu pandemic in fiscal year 2010.  The segment growth was primarily driven by strong sales in Preanalytical Systems safety-engineered products, and Women's Health and Cancer in the Diagnostic Systems unit.

In the BD Biosciences segment, worldwide revenues for the quarter were $314 million, representing an increase of 3.7 percent compared with the prior-year period, or 3.5 percent on a foreign currency-neutral basis.  Segment revenue growth was negatively impacted by about 2 percentage points due to strong sales related to stimulus spending in the U.S. in fiscal year 2010.  Segment growth was primarily driven by instrument and reagent sales in the Cell Analysis unit.

Geographic ResultsFirst quarter revenues in the U.S. were $829 million, representing a decrease of 2.9 percent compared with the prior-year period, including a negative impact of 6.0 percentage points due to flu pandemic-related sales in fiscal year 2010.  Revenues outside of the U.
'/>"/>

SOURCE BD (Becton, Dickinson and Company)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Sangamo BioSciences Announces Presentation at the 13th Annual BIO CEO & Investor Conference
2. BD Announces Agreement to Acquire Accuri Cytometers, Inc.
3. Misonix Announces Completion of Product Registrations in Key Latin American Markets
4. ConvaTec Announces New Appointments to Leadership Team
5. Medivation Announces Participation in 13th Annual BIO CEO & Investor Conference
6. Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements
7. Fairleigh Dickinson University Announces Partnership with Medco Health Solutions, Inc. for New School of Pharmacy
8. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year-End 2010 Financial Results
9. Dendreon Announces Exercise and Closing of Overallotment Option
10. Hospira Announces FDA Approval of Topotecan Injection
11. BioNeutral Group Announces the Formation of Kentucky-Based BioNeutral Services, Inc. and the Appointment of Frank Battafarano as Chairman and CEO of BioNeutral Services, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 23, 2014 Research and Markets ... Gloves (Exam and Surgical) Markets Worldwide 2014" report ... The purpose of this report is ... Medical (Exam and Surgical) Gloves. The report discusses key ... products. Topics covered include product definitions, strategies, ...
(Date:7/23/2014)... , July 23, 2014  Lightlake Therapeutics Inc. ... treatments based on its expertise in opioid antagonists, ... new drug application ("IND") with respect to its ... announced today that it has received an additional ... ("NIDA"), part of the National Institutes of Health ...
(Date:7/23/2014)... , July 23, 2014 This September leading ... Las Vegas for DOCtalk ... educator, author, forward thinker and private practitioner Dr. ... together to candidly discuss clinical and practice management efficiency ... is a unique opportunity to welcome fresh thinking and ...
Breaking Medicine Technology:Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 2Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 3Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 4Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 2Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 32014 DOCtalk Registration Now Open 22014 DOCtalk Registration Now Open 3
... Therapeutics,today announced the presentation of data on the ... American Transplant,meeting to be held in San Francisco, ... with scientists at the University of,Western Ontario., "These ... extend graft,survival in transplantation, and that it can ...
... at Least 75 Percent Improvement in Psoriasis,Signs and ... Dosing Groups, More,Than Half Achieved 90 Percent Improvement, ... New,Phase II study results show Abbott's investigational treatment,ABT-874, ... treated. At 12 weeks, nine out of 10 ...
Cached Medicine Technology:Argos Therapeutics Presents Immunosuppression Data for Soluble CD83,at the American Society of Transplantation Congress 2007 2Abbott's Investigational Treatment ABT-874 Shows Positive Results,in Phase II Psoriasis Study 2Abbott's Investigational Treatment ABT-874 Shows Positive Results,in Phase II Psoriasis Study 3Abbott's Investigational Treatment ABT-874 Shows Positive Results,in Phase II Psoriasis Study 4
(Date:7/23/2014)... 23, 2014 (HealthDay News) -- Regularly checking the pulse ... researchers report. "Screening pulse is the method of ... age 65 who have never had a stroke. Our ... and easy way to identify people who might need ... study author Dr. Bernd Kallmunzer, of Erlangen University in ...
(Date:7/23/2014)... National Institute of Biomedical Imaging and Bioengineering will host ... July 30, 2014 on the NIH campus. There will ... a wide breadth of NIBIB-funded research. , ... Engineering Microbial Rhodopsins as Optical Voltage Sensor, Quyen ... Probes for Nerve Imaging during Surgery, ...
(Date:7/23/2014)... Los Angeles, CA (PRWEB) July 23, 2014 ... physician practices delivering Enhanced External Counterpulsation (EECP), ... patient who receives EECP therapy at the health center. ... and ischemic heart disease. Since receiving ongoing EECP therapy ... , When Sara Soulati, CEO of Global Cardio ...
(Date:7/23/2014)... RIVERSIDE, Calif. Fragile X syndrome ( FXS ) ... behaviors, and other behaviors on the autistic spectrum, as ... inherited cause of mental impairment and the most common ... University of California, Riverside have published a study ... behaviors in FXS. Appearing online today (July 23) in ...
(Date:7/23/2014)... PA (PRWEB) July 23, 2014 Four ... have been lauded in the latest ranking of the ... Report . Released online today and slated for ... Guide recognizes Allegheny General Hospital (AGH), Forbes Hospital, Saint ... medical centers across multiple clinical specialties. , ...
Breaking Medicine News(10 mins):Health News:Routine Pulse Check May Prevent Second Stroke, Study Says 2Health News:Global Cardio Care Celebrates EECP Patient’s 100th Birthday 2Health News:Study links enzyme to autistic behaviors 2Health News:Study links enzyme to autistic behaviors 3Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 2Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 3
... Va., April 16 Since the inaugural National ... than one million advance directive forms have been ... Organization,s Caring Connections program. Today, the 2nd Annual ... age or current health are reminded of the ...
... #H1/F38 - Varian Medical Systems, Inc. (NYSE: VAR ... digital X-ray image detectors will exhibit its line of PaxScan ... the China International Medical Equipment Fair (CMEF) meeting in Shenzhen, ... showcase its full range of X-ray tubes for fluoroscopy, angiography, ...
... For His Discoveries About Attention And Memory, ... 16 NeuroFocus, the world leader in ... application of brainwave-based measurements for market research ... named a Partner in the company,s Consulting ...
... BLOOMINGTON, Minn., April 16 Pearson VUE, the ... it has signed an exclusive agreement with the ... be the exclusive test delivery provider of the ... CCMA examinations are delivered throughout the secure Pearson ...
... Chance to Look Like a Star with Milk on ... Only at bodybymilk.comWASHINGTON , April 16 Warding ... superheroes like Wolverine need a little help. (Photo: ... to rebuild his body far faster than any ordinary ...
... the disease, not the symptoms)HUDSON, Fla., April 16 Workforce Prescriptions ("WRX") announced on ... their unique labor waste derived from 7 sources: , , ... Agency utilization , Other "Premium Pay" ... avoidable days , Process labor waste , ...
Cached Medicine News:Health News:2nd Annual National Healthcare Decisions Day Builds on Growing Awareness of Advance Care Planning 2Health News:Varian Medical Systems to Exhibit the Latest X-Ray Image Detectors, and X-Ray Tubes at the CMEF Show in Shenzhen, China 2Health News:NeuroFocus Appoints Dr. Michael Smith as Partner in Consulting Practice 2Health News:California Certifying Board for Medical Assistants Signs Exclusive Contract with Pearson VUE 2Health News:X-Men's Wolverine Depends on Milk as His X-factor 2Health News:WRX Launches Hospital Labor Waste Calculator 2Health News:WRX Launches Hospital Labor Waste Calculator 3
Round handle colibri tying forceps with 5 mm titanium coated platforms. Length 100 mm....
Barraquer straight tying forceps....
Round handle curved tying forceps with 5 mm titanium coated platforms. Length 110 mm....
Colibri tying forceps with 5 mm titanium coated platforms. Length 85 mm....
Medicine Products: